HQL Net Income Growth
abrdn Life Sciences Investors Shares of Beneficial Interest · Net Income Growth
HQL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported238.33%period ending
HQL Quarterly Net Income YoY % (-30.35% → 238.33%)
Year-over-year change
High-resolution chart · PNG
HQL net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 238.3325% | |
| 279.0769% | |
| -193.9865% | |
| 406.0075% | |
| 48.6747% | |
| 59.5479% | |
| 144.3049% | |
| -185.8214% | |
| -341.8473% | |
| -64.481% | |
| 4.4905% | |
| 395.9711% | |
| 177.2094% | |
| -164.8135% | |
| -98.0505% | |
| 115,809.4052% | |
| -73,799.7947% | |
| -27.2151% | |
| 138.6625% | |
| 213.499% | |
| -176.0999% | |
| -194.0043% | |
| 156.5913% | |
| -8.3473% | |
| 173.3267% | |
| -99.7472% | |
| -99.9761% | |
| 23.881% | |
| 190.4777% | |
| 267.7134% | |
| 267.7134% | |
| 147.0235% | |
| 147.0235% | |
| -135.9668% | |
| -135.9668% | |
| 19.2833% | |
| 19.2833% | |
| 335.5877% | |
| 335.5877% | |
| -147.8999% | |
| -147.8999% | |
| 525.1397% | |
| 525.1397% | |
| -81.4604% | |
| -81.4604% | |
| 176.6118% | |
| 176.6118% | |
| 46.9536% | |
| 46.9536% | |
| -300% | |
| -300% | |
| -30.353% | |
| -30.353% |